How Can We Put COVID Behind Us Without Guaranteed Paid Sick Leave? March 31, 2022 Perspective KHN’s Céline Gounder and KFF’s Mollyann Brodie look at the challenges in returning to normal life after the COVID-19 pandemic when many Americans, particularly people of color and workers with low incomes, do not have paid sick leave.
States Look to Bolster Maternal Health April 1, 2022 Slide Starting April 1, states have a new option to extend Medicaid postpartum coverage from 60 days to 12 months without having to seek a waiver.
Medicaid Spending and Enrollment: Updated for FY 2022 and Looking Ahead to FY 2023 April 4, 2022 Issue Brief In February 2022, the Kaiser Family Foundation (KFF) and Health Management Associates (HMA) fielded a rapid, mini-survey of Medicaid directors in all 50 states and the District of Columbia as a follow-up to the annual Medicaid Budget Survey conducted in summer 2021. This brief explores Medicaid enrollment and spending growth estimates for FY 2022 and projections for FY 2023, as reported by state Medicaid directors.
Many Uninsured People Could Lose Access to Free COVID-19 Testing, Treatment, and Vaccines as Federal Funding Runs Out March 28, 2022 News Release With an impasse in Congress over additional COVID-19 emergency funding, uninsured people could lose access to free testing and treatment services, a new KFF brief explains. For people without health insurance, the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program has reimbursed hospitals, doctors and other providers for the…
Implications of the Lapse in Federal COVID-19 Funding on Access to COVID-19 Testing, Treatment, and Vaccines March 28, 2022 Issue Brief A current impasse in Congress threatens continued funding for COVID-19 testing, treatment, and vaccines. The lack of additional federal COVID-19 funding has broad implications for access to these services, particularly for the uninsured, and could undermine efforts to ensure equitable access to these resources.
KFF COVID-19 Vaccine Monitor: Views on the U.S. Role In Global COVID-19 Response March 25, 2022 Poll Finding This Vaccine Monitor survey shows the public is largely supportive of the U.S. role in distributing COVID-19 vaccines globally, as well as other response efforts including the distribution of masks and COVID-19 rapid tests.
New KFF Analysis Finds That the U.S. Government Does Not Currently Have Enough Vaccine Doses to Fully Cover Every American with a 4th Dose March 25, 2022 News Release With funding for additional COVID-19 support at a stalemate in Congress, a new KFF analysis looks at potential scenarios that United States might face if a 4th COVID-19 vaccine dose is recommended to the public. The analysis finds that the U.S. government does not have enough funding to purchase vaccine…
Many Privately Insured People with Diabetes Could Save Money if Congress Caps Insulin Costs March 24, 2022 News Release Several legislative proposals in Congress propose a $35 per month cap on what people with health insurance would have to pay out of pocket for insulin, a life-saving hormone taken regularly by many people with diabetes to maintain their health. Such a cap could provide financial relief to at least…
Are There Enough COVID-19 Vaccines for America Without More Funding? March 25, 2022 Issue Brief This Data Note estimates how far the current U.S. supply of COVID-19 vaccines could stretch under different vaccination and booster scenarios. While estimated U.S. COVID-19 vaccine supply needs vary widely depending on assumptions and how many people choose to get vaccinated, this analysis indicates that under a plausible set of scenarios where 4th doses are recommended, the federal government is unlikely to have enough doses already purchased to cover the U.S. population.
